> It's a big week for Merck, which is hoping to move two blockbusters--Gardasil and Januvia--past important milestones. Article
> Pfizer won a landmark patent protection case in China, signaling the Chinese government's willingness to protect big drug companies' blockbuster meds. Report (WSJ sub. req.)
> New market research indicates that the growing popularity of Enbrel and Humira will help expand the market for RA drugs to $10 billion in 2015. Release
> Cabrellis Pharmaceuticals announced its launch after its spinout from Conforma Therapeutics, which was sold to Biogen Idec. Report
> WellGen CEO David Evans died after a sudden illness. Release
> Myogen has launched a Phase III trial of Darusentan in patients with resistant hypertension. Release
> The FDA has approved a new wrinkle cream from Allergan. Report
And Finally… Strict mothers were five times more likely to raise overweight children than mothers who were flexible but good at setting rules. Article